Literature DB >> 12791196

Torsion Dystonia in Children.

Vanessa K. Hinson1, Christopher G. Goetz.   

Abstract

Medical treatment of childhood-onset dystonia can lead to substantial improvement of the condition, often with much more pronounced benefit than in adults. The authors give every patient a trial of levodopa to assess the possible diagnosis of dopa-responsive dystonia, followed-up with centrally acting anticholinergics such as trihexiphenydil. If needed, baclofen or clonazepam is added or substituted. In focal dystonia or segmental and generalized dystonia with prominent involvement of specific muscle groups, botulinum toxin injections are often used. Pallidal deep brain stimulation is offered to selected patients with medically refractory dystonia. Treatment of secondary dystonias, caused by such conditions as Wilson's disease, requires therapy for the underlying disorder. Physical therapy, splints, and occupational therapy can be useful in some patients. The authors do not use intrathecal baclofen unless there is evidence of accompanying spasticity.

Entities:  

Year:  2003        PMID: 12791196     DOI: 10.1007/s11940-003-0035-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  15 in total

1.  Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus.

Authors:  P Coubes; A Roubertie; N Vayssiere; S Hemm; B Echenne
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

2.  Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance.

Authors:  S B Bressman; D de Leon; M F Brin; N Risch; R E Burke; P E Greene; H Shale; S Fahn
Journal:  Ann Neurol       Date:  1989-11       Impact factor: 10.422

3.  Human gene for torsion dystonia located on chromosome 9q32-q34.

Authors:  L Ozelius; P L Kramer; C B Moskowitz; D J Kwiatkowski; M F Brin; S B Bressman; D E Schuback; C T Falk; N Risch; D de Leon
Journal:  Neuron       Date:  1989-05       Impact factor: 17.173

4.  Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.

Authors:  J Jankovic; J Orman
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

5.  Double-blind evaluation of trihexyphenidyl in dystonia.

Authors:  R E Burke; S Fahn
Journal:  Adv Neurol       Date:  1983

6.  Use of intrathecal baclofen in the treatment of patients with dystonia.

Authors:  B Ford; P Greene; E D Louis; G Petzinger; S B Bressman; R Goodman; M F Brin; S Sadiq; S Fahn
Journal:  Arch Neurol       Date:  1996-12

7.  Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.

Authors:  J Jankovic
Journal:  Ann Neurol       Date:  1982-01       Impact factor: 10.422

8.  Pallidotomy for generalized dystonia.

Authors:  W G Ondo; J M Desaloms; J Jankovic; R G Grossman
Journal:  Mov Disord       Date:  1998-07       Impact factor: 10.338

Review 9.  Baclofen in the treatment of dystonia.

Authors:  P Greene
Journal:  Clin Neuropharmacol       Date:  1992-08       Impact factor: 1.592

10.  Outcome of selective ramisectomy for botulinum toxin resistant torticollis.

Authors:  B Ford; E D Louis; P Greene; S Fahn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.